|
V.IU. Shilo, L.I. Alihanova, V.P. Babich, K.A. Vishnevskii, I.V. Zhdanova, A.V. Zuev, O.V. Kalachik, L.I. Kotova, A.B. Legotin, A.B. Sabodash, V.N. Suchkov, G.IU. Timokhovskaia, D.M. Toropilov, A.P. Tutin, S.V. Priluckij, L.A. Fedotova, N.G. Khadikova, M.A. Morozova, D.D. Bolsun, E.A. Dokukina, IU.N. Linkova, R.A. Ivanov
Efficacy and safety of the first russian original long-acting erythropoiesis-stimulating agent for the treatment of anemia in patients with chronic renal failure. The results of the international multicenter randomized phase II clinical trial
|
№2 / 2019
|
Русский
